4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The molecular basis of paediatric malarial disease

      chapter-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Severe falciparum malaria is an acute systemic disease that can affect multiple organs, including those in which few parasites are found. The acute disease bears many similarities both clinically and, potentially, mechanistically, to the systemic diseases caused by bacteria, rickettsia, and viruses. Traditionally the morbidity and mortality associated with severe malarial disease has been explained in terms of mechanical obstruction to vascular flow by adherence to endothelium (termed sequestration) of erythrocytes containing mature-stage parasites. However, over the past few decades an alternative ‘cytokine theory of disease’ has also evolved, where malarial pathology is explained in terms of a balance between the pro- and anti-inflammatory cytokines. The final common pathway for this pro-inflammatory imbalance is believed to be a limitation in the supply and mitochondrial utilisation of energy to cells. Different patterns of ensuing energy depletion (both temporal and spatial) throughout the cells in the body present as different clinical syndromes. This chapter draws attention to the over-arching position that inflammatory cytokines are beginning to occupy in the pathogenesis of acute malaria and other acute infections. The influence of inflammatory cytokines on cellular function offers a molecular framework to explain the multiple clinical syndromes that are observed during acute malarial illness, and provides a fresh avenue of investigation for adjunct therapies to ameliorate the malarial disease process.

          Related collections

          Most cited references172

          • Record: found
          • Abstract: found
          • Article: not found

          HMG-1 as a late mediator of endotoxin lethality in mice.

          Endotoxin, a constituent of Gram-negative bacteria, stimulates macrophages to release large quantities of tumor necrosis factor (TNF) and interleukin-1 (IL-1), which can precipitate tissue injury and lethal shock (endotoxemia). Antagonists of TNF and IL-1 have shown limited efficacy in clinical trials, possibly because these cytokines are early mediators in pathogenesis. Here a potential late mediator of lethality is identified and characterized in a mouse model. High mobility group-1 (HMG-1) protein was found to be released by cultured macrophages more than 8 hours after stimulation with endotoxin, TNF, or IL-1. Mice showed increased serum levels of HMG-1 from 8 to 32 hours after endotoxin exposure. Delayed administration of antibodies to HMG-1 attenuated endotoxin lethality in mice, and administration of HMG-1 itself was lethal. Septic patients who succumbed to infection had increased serum HMG-1 levels, suggesting that this protein warrants investigation as a therapeutic target.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The global distribution of clinical episodes of Plasmodium falciparum malaria.

            Interest in mapping the global distribution of malaria is motivated by a need to define populations at risk for appropriate resource allocation and to provide a robust framework for evaluating its global economic impact. Comparison of older and more recent malaria maps shows how the disease has been geographically restricted, but it remains entrenched in poor areas of the world with climates suitable for transmission. Here we provide an empirical approach to estimating the number of clinical events caused by Plasmodium falciparum worldwide, by using a combination of epidemiological, geographical and demographic data. We estimate that there were 515 (range 300-660) million episodes of clinical P. falciparum malaria in 2002. These global estimates are up to 50% higher than those reported by the World Health Organization (WHO) and 200% higher for areas outside Africa, reflecting the WHO's reliance upon passive national reporting for these countries. Without an informed understanding of the cartography of malaria risk, the global extent of clinical disease caused by P. falciparum will continue to be underestimated.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster.

                Bookmark

                Author and article information

                Journal
                978-3-7643-8099-1
                10.1007/978-3-7643-8099-1
                Pediatric Infectious Diseases Revisited
                Pediatric Infectious Diseases Revisited
                978-3-7643-7997-1
                978-3-7643-8099-1
                2007
                : 239-272
                Affiliations
                [4 ]GRID grid.14778.3d, ISNI 0000000089227789, Pediatric Infectious Diseases Department of General Pediatrics, , University Children’s Hospital, ; Moorenstr. 5, 40225 Düsseldorf, Germany
                [5 ]GRID grid.412581.b, ISNI 0000000090246397, Children’s Hospital HELIOS Klinikum, , Witten-Herdecke University, ; Heusnerstr. 40, 42283 Wuppertal, Germany
                [6 ]GRID grid.1001.0, ISNI 0000000121807477, School of Biochemistry and Molecular Biology, , Australian National University, ; Canberra, Australia
                [7 ]GRID grid.156122.3, ISNI 0000000406413260, Department of Paediatrics, , Newcastle General Hospital, ; Newcastle upon Tyne, UK
                Article
                9
                10.1007/978-3-7643-8099-1_9
                7123729
                3773ff7c-f1c2-4b98-9771-bcf03b6d8410
                © Birkhäuser Verlag Basel/Switzerland 2007

                This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

                History
                Categories
                Article
                Custom metadata
                © Birkhäuser Verlag 2007

                falciparum malaria,severe malaria,cerebral malaria,ethyl pyruvate,plasmodium falciparum malaria

                Comments

                Comment on this article